検索結果 - Sarah Sloot

  • 検索結果 1 - 3 結果 / 3
結果の絞り込み
  1. 1
    Developments in Intralesional Therapy for Metastatic Melanoma

    Developments in Intralesional Therapy for Metastatic Melanoma 著者: Sarah Sloot, Omar M. Rashid, Amod A. Sarnaik, Jonathan S. Zager

    出版事項 2016
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies

    Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies 著者: Sarah Sloot, Y. Ann Chen, Xiuhua Zhao, Jamie L. Weber, Jacob J. Benedict, James J. Mulé, Keiran S.M. Smalley, Jeffrey S. Weber, Jonathan S. Zager, Peter Forsyth, Vernon K. Sondak, Geoffrey T. Gibney

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Ligand-Independent EPHA2 Signaling Drives the Adoption of a Targeted Therapy–Mediated Metastatic Melanoma Phenotype

    Ligand-Independent EPHA2 Signaling Drives the Adoption of a Targeted Therapy–Mediated Metastatic Melanoma Phenotype 著者: Kim H.T. Paraiso, Meghna Das Thakur, Bin Fang, John M. Koomen, Inna V. Fedorenko, Jobin K. John, Hensin Tsao, Keith T. Flaherty, Vernon K. Sondak, Jane L. Messina, Elena B. Pasquale, Alejandro Villagra, Uma N. M. Rao, John M. Kirkwood, Friedegund Meier, Sarah Sloot, Geoffrey T. Gibney, Darrin D. Stuart, Hussein A. Tawbi, Keiran S.M. Smalley

    出版事項 2014
    全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: